Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

I could probably be persuaded to support selling Kevetrin to CELG or 72,000,000 shares of CELG. It's currently trading at ~$150 per share. That would be a current value of ~$100 per share of CTIX. I might consider a smaller number if a decent royalty were part of the deal. And we would still have B and P!

I'm enjoying this. Don't wake me up!

BK said...

If Celgene purchases the entire K franchise, it will cost them every cent of their 11 billion in cash and then some. Yes, it would be a wise decision for Celgene; but no, I don't think Celgene's bean counters and attorneys will see it that way. If K is the breakthrough it demonstrated in preclinical work (and that many of s think it is), 35 a share would be leaving 70 a share on the table, IMO.